HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M400174-MCP200v1 4/3/278    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Glossary Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, Y. Q. Articles by Broadie, K. Search for Related Content PubMed PubMed Citation Articles by Zhang, Y. Q. Articles by Broadie, K. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 4:278-290, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Research

Protein Expression Profiling of the Drosophila Fragile X Mutant Brain Reveals Up-regulation of Monoamine Synthesis^*

Yong Q. Zhang^,, David B. Friedman^¶, Zhe Wang^||, Elvin Woodruff, III, Luyuan Pan, Janis O’Donnell^|| and Kendal Broadie^,**

From the Department of Biological Science, Kennedy Center for Research on Human Development and the ^¶ Proteomics and Mass Spectrometry Research Center, Vanderbilt University, Nashville, Tennessee 37232-1634 and the ^|| Department of Biological Sciences, University of Alabama, Tuscaloosa, Alabama 35487-0344

Fragile X syndrome is the most common form of inherited mental retardation, associated with both cognitive and behavioral anomalies. The disease is caused by silencing of the fragile X mental retardation 1 (fmr1) gene, which encodes the mRNA-binding, translational regulator FMRP. Previously we established a disease model through mutation of Drosophila fmr1 (dfmr1) and showed that loss of dFMRP causes defects in neuronal structure, function, and behavioral output similar to the human disease state. To uncover molecular targets of dFMRP in the brain, we use here a proteomic approach involving two-dimensional difference gel electrophoresis analyses followed by mass spectrometry identification of proteins with significantly altered expression in dfmr1 null mutants. We then focus on two misregulated enzymes, phenylalanine hydroxylase (Henna) and GTP cyclohydrolase (Punch), both of which mediate in concert the synthetic pathways of two key monoamine neuromodulators, dopamine and serotonin. Brain enzymatic assays show a nearly 2-fold elevation of Punch activity in dfmr1 null mutants. Consistently brain neurochemical assays show that both dopamine and serotonin are significantly increased in dfmr1 null mutants. At a cellular level, dfmr1 null mutant neurons display a highly significant elevation of the dense core vesicles that package these monoamine neuromodulators for secretion. Taken together, these data indicate that dFMRP normally down-regulates the monoamine pathway, which is consequently up-regulated in the mutant condition. Elevated brain levels of dopamine and serotonin provide a plausible mechanistic explanation for aspects of cognitive and behavioral deficits in human patients.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Bushey, G. Tononi, and C. Cirelli The Drosophila Fragile X Mental Retardation Gene Regulates Sleep Need J. Neurosci., February 18, 2009; 29(7): 1948 - 1961. [Abstract] [Full Text] [PDF]

				C. R. Tessier and K. Broadie Drosophila fragile X mental retardation protein developmentally regulates activity-dependent axon pruning Development, April 15, 2008; 135(8): 1547 - 1557. [Abstract] [Full Text] [PDF]

				L. Pan and K. S. Broadie Drosophila Fragile X Mental Retardation Protein and Metabotropic Glutamate Receptor A Convergently Regulate the Synaptic Ratio of Ionotropic Glutamate Receptor Subclasses J. Neurosci., November 7, 2007; 27(45): 12378 - 12389. [Abstract] [Full Text] [PDF]

				D. B. Friedman, S. E. Wang, C. W. Whitwell, R. M. Caprioli, and C. L. Arteaga Multivariable Difference Gel Electrophoresis and Mass Spectrometry: A Case Study on Transforming Growth Factor-{beta} and ERBB2 Signaling Mol. Cell. Proteomics, January 1, 2007; 6(1): 150 - 169. [Abstract] [Full Text] [PDF]

				J. M. Stein, W. Bergman, Y. Fang, L. Davison, C. Brensinger, M. B. Robinson, N. B. Hecht, and T. Abel Behavioral and neurochemical alterations in mice lacking the RNA-binding protein translin. J. Neurosci., February 22, 2006; 26(8): 2184 - 2196. [Abstract] [Full Text] [PDF]